Literature DB >> 20542739

A physiological role for inducible FOXP3(+) Treg cells. Lessons from women with reproductive failure.

Lourdes Arruvito1, Ana I Sotelo, Ariel Billordo, Leonardo Fainboim.   

Abstract

We have previously shown a decreased frequency and function of Tregs in women suffering from recurrent spontaneous abortions (RSA). In the current study, we first investigated the expression of FOXP3 after T-cell activation. We observed that expression of FOXP3 in activated PBMCs was already present above baseline before any cell division, indicating that it was induced in cells that were previously negative for this transcription factor. Because RSA women showed a more limited expansion of FOXP3-positive cells, we next assessed the role of IL-2 signaling through STAT5, which is known to be required for generation of inducible Tregs (iTregs). We demonstrated not only that TGF-beta and IL-2 were diminished but also that the IL-2-STAT-5 signaling axis was down regulated in RSA women. Finally, in addition to a limited FOXP3(+) cells expansion in vitro, iTregs from RSA women showed a strikingly lower suppressor activity. Copyright 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20542739     DOI: 10.1016/j.clim.2010.05.002

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  10 in total

Review 1.  Regulatory T cells in embryo implantation and the immune response to pregnancy.

Authors:  Sarah A Robertson; Alison S Care; Lachlan M Moldenhauer
Journal:  J Clin Invest       Date:  2018-10-01       Impact factor: 14.808

2.  Evaluation of Th17 and Treg cytokines in patients with unexplained recurrent pregnancy loss.

Authors:  Maral Farshchi; Elham Abdollahi; Nafiseh Saghafi; Ahmad Hosseini; Sara Fallahi; Sirus Rostami; Parifar Rostami; Houshang Rafatpanah; Mojtaba Habibagahi
Journal:  J Clin Transl Res       Date:  2022-05-25

3.  The frequency of CD25+CD4+ and FOXP3+ regulatory T cells in ectopic endometrium and ectopic decidua.

Authors:  Pawel Basta; Marcin Majka; Wojciech Jozwicki; Ewelina Lukaszewska; Anna Knafel; Marek Grabiec; Elzbieta Stasienko; Lukasz Wicherek
Journal:  Reprod Biol Endocrinol       Date:  2010-10-05       Impact factor: 5.211

4.  Peripheral Dendritic Cells and CD4+CD25+Foxp3+ Regulatory T Cells in the First Trimester of Normal Pregnancy and in Women with Recurrent Miscarriage.

Authors:  Maciej Kwiatek; Tomasz Gęca; Arkadiusz Krzyżanowski; Agnieszka Malec; Anna Kwaśniewska
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

5.  Tregitopes regulate the tolerogenic immune response and decrease the foetal death rate in abortion-prone mouse matings.

Authors:  Anna Ewa Kedzierska; Daria Lorek; Anna Slawek; Anna Chelmonska-Soyta
Journal:  Sci Rep       Date:  2020-06-29       Impact factor: 4.379

Review 6.  New Paradigm in the Role of Regulatory T Cells During Pregnancy.

Authors:  Sayaka Tsuda; Akitoshi Nakashima; Tomoko Shima; Shigeru Saito
Journal:  Front Immunol       Date:  2019-03-26       Impact factor: 7.561

Review 7.  Therapeutic Potential of Regulatory T Cells in Preeclampsia-Opportunities and Challenges.

Authors:  Sarah A Robertson; Ella S Green; Alison S Care; Lachlan M Moldenhauer; Jelmer R Prins; M Louise Hull; Simon C Barry; Gustaaf Dekker
Journal:  Front Immunol       Date:  2019-03-21       Impact factor: 7.561

Review 8.  Genetics of recurrent pregnancy loss among Iranian population.

Authors:  Meysam Moghbeli
Journal:  Mol Genet Genomic Med       Date:  2019-07-30       Impact factor: 2.183

Review 9.  The Role of Immune Cells in Recurrent Spontaneous Abortion.

Authors:  Dan Li; Lianwen Zheng; Donghai Zhao; Ying Xu; Yeling Wang
Journal:  Reprod Sci       Date:  2021-06-08       Impact factor: 3.060

Review 10.  The Endocrine Milieu and CD4 T-Lymphocyte Polarization during Pregnancy.

Authors:  Barbara Polese; Virginie Gridelet; Eleni Araklioti; Henri Martens; Sophie Perrier d'Hauterive; Vincent Geenen
Journal:  Front Endocrinol (Lausanne)       Date:  2014-07-07       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.